Injections for giddiness

Reading File
Finding Sources
Finding Sources
Searching the Web

injections for vertigo giddiness treatment prochlorperazine betahistine

Reading File
Reading File
Finding Sources
Reading File
Reading File
Here is a thorough, textbook-sourced overview of injections used for giddiness (vertigo):

Injections for Giddiness (Vertigo)

Giddiness/vertigo is managed with several injectable drugs depending on the setting - acute attacks in the emergency department, refractory Meniere's disease, or vestibular neuritis. Treatment falls into symptomatic (vestibular suppressants) and specific (disease-modifying) categories.

1. Symptomatic Injections (Acute Vertigo Attack)

Ondansetron (IV) - First Line

  • Dose: 4 mg IV
  • A 5-HT3 serotonin receptor antagonist; used as the first-line IV agent for symptomatic vertigo in the emergency setting
  • A randomized trial comparing IM promethazine vs IV ondansetron in acute peripheral vertigo showed excellent improvement in both groups, with fewer side effects with ondansetron
    • Rosen's Emergency Medicine, p. 3856

Promethazine (IM) - Highly Effective but Caution Needed

  • Dose: 12.5-25 mg IM; also available as 25 mg suppository
  • Likely the most effective parenteral vestibular suppressant, but the FDA has issued a boxed warning against IV use (risk of tissue necrosis); IM or oral routes are preferred
  • Useful when vomiting prevents oral intake
    • Rosen's Emergency Medicine, p. 3854-3856

Prochlorperazine (IV/IM) - Dopamine Antagonist

  • Dose: 5-10 mg IV or IM (Stemetil®)
  • A phenothiazine dopamine antagonist that blocks the chemoreceptor trigger zone and vomiting centre, which receives afferent input from the vestibular apparatus
  • Available as injection, tablets, suppositories, and buccal preparation (Buccastem®) - the non-oral forms are particularly useful since vomiting patients cannot absorb oral doses
  • Notable side effects: extra-pyramidal effects (more pronounced than other phenothiazines), less sedating
  • Do NOT use in dizziness caused by orthostatic hypotension
    • Scott-Brown's Otorhinolaryngology, p. 4545-4565

Diazepam (IV) - Benzodiazepine

  • Dose: 5 mg IV
  • Useful in prolonged, severe vertigo episodes; patients prefer lying still in a dark quiet room and this agent helps
  • Benzodiazepines (e.g., lorazepam 1-2 mg IV) can be given when vertigo is intractable and unresponsive to antiemetics
  • Caution: Not recommended for discharge prescriptions in vestibular neuritis/labyrinthitis as benzodiazepines interfere with vestibular habituation/compensation
    • Goldman-Cecil Medicine, p. 3564; Rosen's Emergency Medicine, p. 3856

Cyclizine (IM) - Antihistamine

  • Dose: 50 mg three times a day, may be given parenterally
  • H1-receptor antagonist; acts mainly on the vomiting centre
  • Less sedating than promethazine
    • Scott-Brown's Otorhinolaryngology, p. 4581-4583

2. Specific / Disease-Modifying Injections

Intratympanic Gentamicin - Meniere's Disease

  • Injected through the tympanic membrane (or via grommet/round window catheter) directly into the middle ear
  • Exploits gentamicin's vestibulotoxic effect - destroys vestibular hair cell function ("chemical/partial labyrinthectomy")
  • Highly effective for controlling recurrent vertigo attacks in refractory unilateral Meniere's disease
  • Risk: Hearing loss (varies with dose and frequency)
    • Scott-Brown's Otorhinolaryngology, p. 4588-4595

Intratympanic Methylprednisolone / Dexamethasone - Meniere's Disease

  • Injected intratympanically for refractory vertigo in Meniere's disease
  • Intratympanic methylprednisolone is comparable to intratympanic gentamicin in reducing vertiginous attacks but preserves hearing - preferred when residual hearing needs to be protected
  • Intratympanic dexamethasone achieved substantial vertigo control in ~61% of patients in one series
    • Goldman-Cecil Medicine, p. 3562; Scott-Brown's Vol 2, p. 6326

Methylprednisolone (systemic IV/IM) - Vestibular Neuritis

  • Dose: 1 mg/kg/day for 5 days, then tapered over 15 days
  • Effective (at least short-term) for vestibular neuritis; antiviral agents have NOT been shown to add benefit
    • Goldman-Cecil Medicine, p. 3562

3. Summary Table

DrugRouteDoseMain Use
OndansetronIV4 mgAcute vertigo (1st line IV)
PromethazineIM12.5-25 mgAcute vertigo with vomiting
ProchlorperazineIV/IM5-10 mgAcute vertigo/nausea
Diazepam/LorazepamIV5 mg / 1-2 mgSevere/intractable vertigo
CyclizineIM50 mgAcute vertigo (antihistamine)
MethylprednisoloneIV/IM (systemic)1 mg/kg/dayVestibular neuritis
Intratympanic gentamicinIntratympanicVariableRefractory Meniere's (ablative)
Intratympanic steroidIntratympanicVariableRefractory Meniere's (hearing preserved)

Key Clinical Points

  • Acute attacks: Start with IV ondansetron 4 mg; use IM promethazine if needed (avoid IV route)
  • Intractable vertigo unresponsive to antiemetics: Add IV lorazepam 1-2 mg
  • Vestibular neuritis: Systemic corticosteroids (methylprednisolone); avoid prolonged benzodiazepines
  • Refractory Meniere's with good hearing: Intratympanic steroids preferred over gentamicin
  • Refractory Meniere's, hearing already lost: Intratympanic gentamicin for definitive vestibular ablation
  • Do not use prochlorperazine or chlorpromazine if dizziness is from orthostatic hypotension
This is a shared conversation. Sign in to Orris to start your own chat.